Idorsia Ltd (IDIA.S)
22 Jun 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||Non-Executive Chairman of the Board|
|62||Chief Executive Officer, Member of the Board|
|53||Chief Financial Officer, Executive Vice President, Member of the Executive Board|
|61||Executive Vice President, Chief Scientific Officer, Member of the Executive Board|
|60||Executive Vice President, head of global clinical development, Member of the Executive Board|
- After split from Actelion, Idorsia CEO plans to raise more cash in 2019
- BRIEF-Idorsia Initiates Phase 3 Registration Program With Nemorexant For Treatment Of Insomnia
- BRIEF-Idorsia Starts Phase 3 Registration Study To Assess Lucerastat As Potential New Treatment Option For Patients With Fabry Disease
- BRIEF-Idorsia: US GAAP Oper Loss Of CHF 74 Mln In Q1 2018
- BRIEF-Idorsia FY US GAAP Loss Of CHF 8 Million